Myriad Genetics Reports Preliminary Q4 Revenue; Issues 2026 Guidance

Financial Projections - Myriad Genetics, Inc. expects fourth quarter total revenues to be between $207 million and $209 million [1] - For the full year 2025, total revenues are projected to be between $822 million and $824 million [1] - For the full year 2026, the company projects revenue in a range of $860 million to $880 million and adjusted EBITDA in a range of $37 million to $49 million [1] Earnings Call - The company plans to release its actual financial results for the fourth quarter during its earnings call scheduled for February 2026 [1]